Geraldine Murden

Osteonecrosis of the Jaw and Oral Health–Related Quality of Life After Adjuvant Zoledronic Acid: An Adjuvant Zoledronic Acid to Reduce Recurrence Trial Subprotocol (BIG01/04)

Emma Rathbone, Janet E. Brown, Helen Marshall et al. · Journal of Clinical Oncology · 2013 · 56 citations · Full text

Pharmacy, Oncology, Breast Oncology +12

CONCORDE: A phase I platform study of novel agents in combination with conventional radiotherapy in non-small-cell lung cancer

Gerard Walls, Jamie B. Oughton, Anthony J. Chalmers et al. · Clinical and Translational Radiation Oncology · 2020 · 34 citations · Full text

Medicine, Oncology, Radiation Oncology +16

Lapatinib plus Capecitabine versus Trastuzumab plus Capecitabine in the Treatment of Human Epidermal Growth Factor Receptor 2-positive Metastatic Breast Cancer with Central Nervous System Metastases for Patients Currently or Previously Treated with Trastuzumab (LANTERN): a Phase II Randomised Trial

Jenny F. Seligmann, Alexandra Wright‐Hughes, A. Pottinger et al. · Clinical Oncology · 2020 · 20 citations

Medicine, Oncology, Pharmacology +17

Mirtazapine to alleviate severe breathlessness in patients with COPD or interstitial lung diseases (BETTER-B): an international, multicentre, double-blind, randomised, placebo-controlled, phase 3 mixed-method trial

Irene J Higginson, Sarah T Brown, Adejoke O Oluyase et al. · The Lancet Respiratory Medicine · 2024 · 20 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

PRISM protocol: a randomised phase II trial of nivolumab in combination with alternatively scheduled ipilimumab in first-line treatment of patients with advanced or metastatic renal cell carcinoma

Hannah Buckley, Fiona Collinson, Gemma Ainsworth et al. · BMC Cancer · 2019 · 17 citations · Full text

Medicine, Oncology, Pharmacology +17